Q2 2025 13F Holders as of 6/30/2025
-
Type / Class
-
Equity / Common stock, par value $0.0001 per share (the "Shares")
-
Shares outstanding
-
22.4M
-
Number of holders
-
42
-
Total 13F shares, excl. options
-
9.79M
-
Shares change
-
-3.21M
-
Total reported value, excl. options
-
$9.88M
-
Value change
-
-$4.66M
-
Number of buys
-
18
-
Number of sells
-
-37
-
Price
-
$1.01
Significant Holders of Boundless Bio, Inc. - Common stock, par value $0.0001 per share (the "Shares") (BOLD) as of Q2 2025
63 filings reported holding BOLD - Boundless Bio, Inc. - Common stock, par value $0.0001 per share (the "Shares") as of Q2 2025.
Boundless Bio, Inc. - Common stock, par value $0.0001 per share (the "Shares") (BOLD) has 42 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 9.79M shares
of 22.4M outstanding shares and own 43.7% of the company stock.
Largest 10 shareholders include FMR LLC (3.13M shares), Nextech Invest, Ltd. (1.23M shares), CITADEL ADVISORS LLC (831K shares), SECTORAL ASSET MANAGEMENT INC (679K shares), Redmile Group, LLC (589K shares), WELLINGTON MANAGEMENT GROUP LLP (556K shares), VANGUARD GROUP INC (481K shares), Alyeska Investment Group, L.P. (300K shares), Almitas Capital LLC (236K shares), and MILLENNIUM MANAGEMENT LLC (214K shares).
This table shows the top 42 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.